Search research articles
Contact Us
Filters
Showing results (51-60 of 94) with videos related to
Page
of 10
Sort By:
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS
|
April 23, 2002
Binding characteristics of [(3)H]-irbesartan to human recombinant angiotensin type 1 receptors
P M Vanderheyden, I Verheijen, F L Fierens, et al.
Clinical Pharmacology and Therapeutics
|
February 13, 2009
Delivery of biologics in cardiovascular regenerative medicine
J Bartunek, W Sherman, M Vanderheyden, et al.
Regulatory Peptides
|
November 5, 1998
Effect of BIBP3226 on inositol phosphate accumulation and cytosolic calcium level in control and NPY Y1 receptor expressing CHO-K1 cells
P M Vanderheyden, I Van Liefde, J P DeBacker, et al.
Current Research in Neurobiology
|
May 31, 2021
The transcriptional repressor Rev-erbα regulates circadian expression of the astrocyte Fabp7 mRNA
William M Vanderheyden, Bin Fang, Carlos C Flores, et al.
Neuroglia (Basel, Switzerland)
|
March 13, 2023
Fabp7 Is Required for Normal Sleep Suppression and Anxiety-Associated Phenotype following Single-Prolonged Stress in Mice
William M Vanderheyden, Micah Lefton, Carlos C Flores, et al.
Physiological Reports
|
February 23, 2021
Rat models for low and high adaptive response to exercise differ for stress-related memory and anxiety
William M Vanderheyden, Michaela Kehoe, Giancarlo Vanini, et al.
Pharmaceutical Research
|
April 17, 2001
Inhibition of angiotensin II-induced inositol phosphate production by triacid nonpeptide antagonists in CHO cells expressing human AT1 receptors
P M Vanderheyden, I Verheijen, F L Fierens, et al.
European Journal of Pharmacology
|
June 9, 1998
Human neuropeptide YY1 receptors exert unequal control of the extracellular acidification rate in different cell lines
I Van Liefde, P M Vanderheyden, N Fraeyman, et al.
Biochemical Pharmacology
|
February 15, 2001
A two-state receptor model for the interaction between angiotensin II type 1 receptors and non-peptide antagonists
G Vauquelin, P Morsing, F L Fierens, et al.
British Journal of Pharmacology
|
April 8, 1999
Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors
P M Vanderheyden, F L Fierens, J P De Backer, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 94) with videos related to
Sort By:
Page
of 10
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS
|
April 23, 2002
Binding characteristics of [(3)H]-irbesartan to human recombinant angiotensin type 1 receptors
P M Vanderheyden, I Verheijen, F L Fierens, et al.
Clinical Pharmacology and Therapeutics
|
February 13, 2009
Delivery of biologics in cardiovascular regenerative medicine
J Bartunek, W Sherman, M Vanderheyden, et al.
Regulatory Peptides
|
November 5, 1998
Effect of BIBP3226 on inositol phosphate accumulation and cytosolic calcium level in control and NPY Y1 receptor expressing CHO-K1 cells
P M Vanderheyden, I Van Liefde, J P DeBacker, et al.
Current Research in Neurobiology
|
May 31, 2021
The transcriptional repressor Rev-erbα regulates circadian expression of the astrocyte Fabp7 mRNA
William M Vanderheyden, Bin Fang, Carlos C Flores, et al.
Neuroglia (Basel, Switzerland)
|
March 13, 2023
Fabp7 Is Required for Normal Sleep Suppression and Anxiety-Associated Phenotype following Single-Prolonged Stress in Mice
William M Vanderheyden, Micah Lefton, Carlos C Flores, et al.
Physiological Reports
|
February 23, 2021
Rat models for low and high adaptive response to exercise differ for stress-related memory and anxiety
William M Vanderheyden, Michaela Kehoe, Giancarlo Vanini, et al.
Pharmaceutical Research
|
April 17, 2001
Inhibition of angiotensin II-induced inositol phosphate production by triacid nonpeptide antagonists in CHO cells expressing human AT1 receptors
P M Vanderheyden, I Verheijen, F L Fierens, et al.
European Journal of Pharmacology
|
June 9, 1998
Human neuropeptide YY1 receptors exert unequal control of the extracellular acidification rate in different cell lines
I Van Liefde, P M Vanderheyden, N Fraeyman, et al.
Biochemical Pharmacology
|
February 15, 2001
A two-state receptor model for the interaction between angiotensin II type 1 receptors and non-peptide antagonists
G Vauquelin, P Morsing, F L Fierens, et al.
British Journal of Pharmacology
|
April 8, 1999
Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors
P M Vanderheyden, F L Fierens, J P De Backer, et al.
Page
of 10